Vitalinda Pumo
Overview
Explore the profile of Vitalinda Pumo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scalia G, Ferini G, Shams Z, Graziano F, Ponzo G, Giurato E, et al.
Curr Oncol
. 2024 Dec;
31(12):7459-7475.
PMID: 39727674
(1) Background: Testicular cancer, although accounting for only 0.5% to 1% of all solid male cancers, is the most common malignancy in males aged 15 to 35 years. Non-seminomatous germ...
2.
Pumo V, Tralongo A, Di Mari A, Iacono M, Giuliano S, Lanteri E, et al.
Recenti Prog Med
. 2015 Aug;
106(8):358-63.
PMID: 26228858
The number of cancer survivors is progressively increasing. Despite the significant progress in the cancer therapies, we are facing the emerging concern of the late side effects and/or psycosocial problems...
3.
Bordonaro S, Raiti F, Di Mari A, Lopiano C, Romano F, Pumo V, et al.
J Multidiscip Healthc
. 2012 Jul;
5:137-43.
PMID: 22807631
Background: Active home-based treatment represents a new model of health care. Chronic treatment requires continuous access to facilities that provide cancer care, with considerable effort, particularly economic, on the part...
4.
Pumo V, Milone G, Iacono M, Giuliano S, Di Mari A, Lopiano C, et al.
Cancer Manag Res
. 2012 Mar;
4:61-5.
PMID: 22427732
Background: The progressive increase in the number of patients surviving long term after a diagnosis of malignant disease has led to a focus on the early and late complications of...
5.
Pumo V, Sciacca D, Malaguarnera M
Crit Rev Oncol Hematol
. 2007 Jul;
64(1):31-42.
PMID: 17658268
The majority of cancers occur in adults over the age of 65, with about 70% of all cancer deaths in this population. Tumor lysis syndrome (TLS) is a complication of...